1h Free Analyst Time
The microfluidics for healthcare application market is forecasted to grow by USD 110.2 billion during 2023-2028, accelerating at a CAGR of 27.16% during the forecast period. The report on the microfluidics for healthcare application market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by compact size of microfluidic devices, growth in lifestyle diseases, and advances in dna sequencing.
The microfluidics for healthcare application market is segmented as below:
By Application
- In-vitro diagnostics
- Pharmaceutical research
- Drug delivery services
By Material
- Polymer-based
- Glass-based
- Silicon-based
By Geography
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the microfluidics for healthcare application market covers the following areas:
- Microfluidics for healthcare application market sizing
- Microfluidics for healthcare application market forecast
- Microfluidics for healthcare application market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Material
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
908 Devices Inc. - Key offerings
13 Appendix
360 degree market analysis
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global microfluidics for healthcare application market: 908 Devices Inc., Agilent Technologies Inc., BioMerieux SA, Bio Rad Laboratories Inc., Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Fluigent SA, General Electric Co., Hamilton Co., Illumina Inc., Microfluidic Chipshop GmbH, MICRUX FLUIDIC S.L., Perkin Elmer Inc., QIAGEN NV, SMC Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., and uFluidix Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is use of paper-based microfluidic devices."
According to the report, one of the major drivers for this market is the compact size of microfluidic devices.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 908 Devices Inc.
- Agilent Technologies Inc.
- BioMerieux SA
- Bio Rad Laboratories Inc.
- Blacktrace Holdings Ltd.
- Cellix Ltd.
- Danaher Corp.
- Elveflow
- Fluigent SA
- General Electric Co.
- Hamilton Co.
- Illumina Inc.
- Microfluidic Chipshop GmbH
- MICRUX FLUIDIC S.L.
- Perkin Elmer Inc.
- QIAGEN NV
- SMC Corp.
- Teledyne Technologies Inc.
- Thermo Fisher Scientific Inc.
- uFluidix Inc.
